Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    3.00 (2.11%)
Bid:
140.50
Ask:
144.50
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

14 Jan 2026 07:00

RNS Number : 7757O
Xaar PLC
14 January 2026
 

 

14 January 2026

 

 

Xaar plc

("Xaar", the "Group" or the "Company")

 

2025 trading update and notification of full year results

 

Xaar, the inkjet printing technology Group, today issues a trading update for the year ended 31 December 2025.

 

Revenue in the twelve months to 31 December 2025 is expected to be up 16.6% on a like-for-like basis (adjusting for currency and ceased operations) at £60.3 million (2024: £61.4 million,) 

 

Revenues in core ceramics segments have been stable, with growth coming from newer products and markets, notably jewellery wax. Printhead revenue growth was 28.9%.

 

Gross margins have benefitted from volume performance and cost control and the Group expects full year adjusted profits to be marginally ahead of expectation.

 

The year-end net cash position is around £4.8m (2024: £8.2m) after capital investment of £3.1m.

 

Xaar's differentiated technology allows the precise deposition of specialist fluids. Over the last five years the Group has been developing this unique capability for new applications beyond its core ceramics market. The benefits of these developments are evident in 2025 revenues and, while the timing of such projects can be uncertain, the Board is optimistic about the range and scale of the opportunities ahead.

 

Xaar is pleased to announce the appointment of Joh. Berenberg, Gossler & Co KG, London Branch ("Berenberg") and Singer Capital Markets ("Singer") as joint Corporate Brokers, with immediate effect.

 

The full year results will be published on Tuesday 24 March 2026 and there will be a meeting for analysts and institutional investors at 9.15am on the day. For details, please contact Xaar via investor.relations@Xaar.com.

 

Berenberg +44 (0)20 3207 7800

Harry Nicholas

Tom Ballard

 

Singer +44 (0)207 496 3000

Sara Hale

Graham Hertrich

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKXLFFQFLZBBX
Date   Source Headline
13th Mar 20094:35 pmRNSPrice Monitoring Extension
6th Mar 20099:00 amRNSHolding(s) in Company
4th Mar 20097:00 amRNSNotice of Final Results
24th Feb 20097:00 amRNSNew product launch
18th Feb 200912:15 pmRNSDirector/PDMR Shareholding
16th Jan 20093:45 pmRNSHolding(s) in Company
15th Jan 20097:00 amRNSFull Year Trading Update
14th Jan 20093:00 pmRNSHolding(s) in Company
7th Jan 20094:15 pmRNSHolding(s) in Company
7th Jan 20099:00 amRNSHolding(s) in Company
23rd Dec 20083:57 pmRNSHolding(s) in Company
16th Dec 20084:40 pmRNSSecond Price Monitoring Extn
16th Dec 20084:35 pmRNSPrice Monitoring Extension
1st Dec 20083:10 pmRNSDirector/PDMR Shareholding
28th Nov 20089:00 amRNSDirector/PDMR Shareholding
26th Nov 20087:00 amRNSTrading Update
24th Nov 20084:40 pmRNSPrice Monitoring Extension
12th Nov 20084:05 pmRNSDirector/PDMR Shareholding Replacement
12th Nov 20083:03 pmRNSDirector/PDMR Shareholding
21st Oct 20089:00 amRNSHolding(s) in Company
15th Oct 20087:00 amRNSInterim Management Statement
13th Oct 20084:41 pmRNSSecond Price Monitoring Extn
13th Oct 20084:36 pmRNSPrice Monitoring Extension
30th Sep 20087:00 amRNSNotice of IMS
5th Sep 200810:00 amRNSBlocklisting Interim Review -
5th Sep 20089:08 amRNSBlocklisting Interim Review
4th Sep 20089:00 amRNSHolding(s) in Company
3rd Sep 20084:14 pmRNSDirector/PDMR Shareholding
28th Aug 200810:27 amRNSDirector/PDMR Shareholding
20th Aug 20087:00 amRNSHalf Yearly Report and Result
6th Aug 20087:00 amRNSNotice of Half Year Report
29th Jul 20089:39 amRNSHolding(s) in Company
25th Jul 20081:46 pmRNSHolding(s) in Company
15th Jul 200810:46 amRNSHolding(s) in Company
11th Jul 20087:00 amRNSPeriod end update & new broke
5th Jun 20086:00 pmRNSTotal Voting Rights
30th May 20087:00 amRNSAnalyst/investor visit to Dru
23rd May 20087:00 amRNSChina business update: recent
15th May 20082:49 pmRNSHolding(s) in Company
14th May 200810:10 amRNSDirectorate Change
13th May 200812:04 pmRNSResult of AGM
13th May 200812:04 pmRNSResult of AGM
13th May 20086:00 amRNSInterim Management & AGM Stat
9th May 200811:48 amRNSTotal Voting Rights
29th Apr 20082:23 pmRNSDirector/PDMR Shareholding
28th Apr 20084:35 pmRNSHolding(s) in Company
28th Apr 20087:00 amRNSDrupa exhibition preview
10th Apr 20083:50 pmRNSAnnual Information Update
2nd Apr 20085:43 pmRNSTotal Voting Rights
27th Mar 20086:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.